New approved uses of antineoplastic agents during the COVID-19 pandemic in Colombia- Part 1: Oral antineoplastic agents, cytotoxic agents, and monoclonal antibodies excluding immune checkpoint inhibitors.
Mauricio
Lema Medina,
Néstor
Llinás,
Andrés
Bravo,
Juan Camilo
Hernández
Visitas Artículo 874 |
Visitas PDF 691
Publicado: 2023-08-03